Welcome to our dedicated page for Inogen news (Ticker: INGN), a resource for investors and traders seeking the latest updates and insights on Inogen stock.
Inogen Inc. (INGN) is a pioneering medical technology company committed to enhancing the quality of life for supplemental oxygen users. Founded in 2001, Inogen emerged from a personal story of necessity and innovation. The company's mission began when Mae, the grandmother of one of the founders, was prescribed oxygen therapy, highlighting the need for more user-friendly and portable oxygen solutions. You can learn more about Mae's story here.
Inogen aims to revolutionize oxygen therapy technology, striving to keep pace with the active lifestyles of patients who rely on oxygen to lead fulfilling lives. The company estimates that over 2.5 million patients in the United States and more than 4.5 million patients worldwide use oxygen therapy.
The company's flagship product, the Inogen One system, is a compact, lightweight, and travel-approved portable oxygen concentrator designed to liberate patients from the constraints of heavy tanks, frequent refills, and stationary systems. This innovation provides patients with the freedom and independence to live their lives by moments, not by the minutes left in an oxygen tank.
Inogen's products and services are sold through various channels, including home medical equipment providers, distributors, large gas companies, and home oxygen providers. The company also rents its products directly to patients, generating the majority of its revenue within the United States.
Inogen's commitment to continuous improvement is evident in its ongoing projects and recent achievements. The company constantly works toward refining its product offerings and expanding its reach to benefit more patients globally.
Inogen, Inc. (Nasdaq: INGN) is set to announce its first quarter 2023 financial results after market close on May 4, 2023. The company will host a conference call on the same day at 2:00 p.m. PT / 5:00 p.m. ET. Investors can access the call by dialing (888) 645-4404 for US callers and (862) 298-0702 for international callers. A live webcast will also be available on Inogen’s Investor Relations website at http://investor.inogen.com/, which will be archived for six months. A replay of the call will be accessible starting three hours post-call until May 11, 2023.
Inogen, Inc. (Nasdaq: INGN) announced its participation in the 22nd Annual Needham Virtual Healthcare Conference on April 19, 2023, at 12:45 p.m. ET. The event will include a live audio webcast and an archived recording accessible via the News / Events section of Inogen's Investor Relations website. As a leader in the medical technology sector, Inogen specializes in innovative respiratory products for homecare settings, focusing on portable oxygen concentrators for chronic respiratory conditions. For more details, visit www.inogen.com.
Inogen, Inc. has appointed Tom West to its Board of Directors, effective April 1, 2023, while Kristen Miranda will retire on March 31, 2023. Tom West brings extensive experience from various leadership roles in the medical technology sector, including his recent position as CEO of Intersect ENT, Inc.. The Board's chair, Elizabeth Mora, emphasizes West's potential to enhance Inogen's strategic initiatives and operational efficiency. West expressed enthusiasm for driving growth at Inogen, which specializes in respiratory care products. This change is part of the company's efforts to strengthen its leadership amidst ongoing transformation.
Inogen, a medical technology company focused on innovative respiratory products, will participate in a virtual fireside chat at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on March 21, 2023, at 2:15 p.m. Eastern Time. The chat aims to enhance engagement with investors and provide insights into Inogen's operations. A live audio webcast and an archived recording will be accessible through the company's Investor Relations website. Inogen specializes in portable oxygen concentrators, supporting patients with chronic respiratory conditions.
Inogen, Inc. (Nasdaq: INGN), a medical technology company specializing in respiratory products, will host a conference call on February 27, 2023, at 10:00 a.m. Eastern Time. President and CEO Nabil Shabshab and CFO Kristin Caltrider will discuss the company's commercial and innovation strategies. A live audio webcast and archived recording will be available on Inogen's Investor Relations website. Inogen aims to enhance patient respiratory care through innovative portable oxygen concentrators, partnering with various healthcare stakeholders to ensure accessibility and mobility for patients suffering from chronic respiratory conditions.
Inogen, a medical technology company, reported a 15.3% year-over-year revenue growth for Q4 2022, totaling $88.1 million, driven by increased rental revenue and business-to-business sales. However, the company faced a GAAP net loss of $56.6 million due to a one-time loss related to an intangible asset. For the full year 2022, total revenue rose 5.4% to $377.2 million, but GAAP net losses expanded to $83.8 million. Operating expenses surged 42.8% year-over-year, reflecting strategic investments. Despite challenges, Inogen aims to focus on its innovation pipeline for future growth.
Inogen, Inc. (Nasdaq: INGN) has achieved significant regulatory milestones, including EU MDR certification and FDA 510(k) clearance for its portable oxygen concentrators. The EU certification allows Inogen to market the Inogen One G4 and G5 in Europe, while the FDA clearance for the new Rove 4 model enhances its U.S. product lineup. The Rove 6 has already launched in Europe, with plans for the Rove 4 release in the U.S. in late 2023. These advancements affirm Inogen’s commitment to innovation in respiratory care for patients requiring oxygen therapy.
Inogen, Inc. (Nasdaq: INGN) has released preliminary revenue estimates for Q4 and full year 2022, projecting revenues between
Inogen, Inc. (NASDAQ: INGN), a medical technology company specializing in respiratory products, has announced its participation in the 41st Annual J.P. Morgan Healthcare Conference. President and CEO Nabil Shabshab will present on January 11, 2023, at 10:30 a.m. PT. A live webcast of the presentation will be available on the Inogen Investor Relations website, where archived recordings can also be accessed. Inogen is known for its innovative portable oxygen concentrators designed for patients with chronic respiratory conditions.
FAQ
What is the current stock price of Inogen (INGN)?
What is the market cap of Inogen (INGN)?
What does Inogen Inc. do?
What is Inogen's flagship product?
How does Inogen sell its products?
Where does Inogen generate most of its revenue?
How many patients use oxygen therapy according to Inogen?
What makes Inogen's products stand out?
What is the mission of Inogen Inc.?
Who inspired the founding of Inogen?
Where can I learn more about Inogen's history?
What is Inogen Inc.'s stock symbol?
